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ABSTRACT
Introduction: The purpose of the current study
was to examine the painful elbow, and in par-
ticular enthesitis, in psoriatic arthritis (PsA) and
rheumatoid arthritis (RA) using clinical exami-
nation, ultrasonography (US) and magnetic
resonance imaging (MRI).
Methods: Patients with elbow pain (11 with PsA
and 9 with RA) were recruited. Clinical exami-
nation, US and MRI studies were performed on
the same day. For enthesitis, the common
extensor and flexor insertions and the triceps
insertionwere imaged (20 patients, giving a total
of 60 sites with comparative data). Imaging was
performed with the radiologists blinded to the
diagnosis and clinical findings. US was used to
assess ‘inflammatory activity’ (Power Doppler
signal, oedema, tendon thickening and bursal
swelling) and ‘damage’ (erosions, cortical
roughening and enthesophytes). MRI was used
to assess ‘inflammation’ (fluid in paratenon,
peri-entheseal soft-tissue oedema, entheseal
enhancement with gadolinium, entheseal
oedema and bone oedema) and ‘damage’ (ero-
sion, cortical roughening and enthesophyte).
Results: Complete scan data were not available
for all patients as one patient could not tolerate
the MRI examination. No significant differences
in imaging scores were found between PsA and
RA. Analysis of damage scores revealed com-
plete agreement between US and MRI data in
43/55 (78%) comparisons; in 10/55 (18%) cases
the US data were abnormal but the MRI data
normal; in 2/55 (4%) cases, the MRI data were
abnormal and the US data normal. Analysis of
the inflammation scores revealed complete
agreement between US and MRI data in 33/55
(60%) comparisons; in 3/55 (5%) cases US data
were abnormal but MRI data normal; in 19/55
(35%) cases the MRI data were abnormal and
the US data normal. There was a poor relation-
ship between assessments based on clinical
examination and imaging studies. Readers
could not accurately identify the disease from
imaging findings.
Conclusion: Based on our results, at the elbow,
US and MR have different roles in assessing
enthesitis, with US apparently the better diag-
nostic tool for assessing damage and MR the
better tool for assessing inflammation. In this
study enthesitis and synovitis in the painful
elbow were found equally in cases of established
RA and PsA.
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INTRODUCTION
Enthesitis is an important aspect of spondy-
loarthropathy. It plays a pivotal part in the
spinal changes which occur in ankylosing
spondylitis (AS) and may have a similar role in
the peripheral arthritis of psoriatic arthritis
(PsA) and other spondyloarthropathies. Enthe-
sitis is assessed separately in clinical studies of
AS and PsA and was placed in the ‘outer circle’
(recommended for clinical trials) of domains
determined for PsA at the Outcomes in
Rheumatology Clinical Trials (OMERACT)
meeting in Malta 2006 [1]. Further, enthesitis
assessment is included in the domains in three
composite measures of disease activity in PsA
[2–4].
RA is a different disease to PsA in terms of
genetics, pathogenesis, presentation and out-
come. It has been hypothesised that the pri-
mary pathological lesion occurs in the
synovium in RA and at the enthesis in PsA [5].
According to this hypothesis, synovitis in PsA is
considered to be secondary to the extra-capsular
disease. On the other hand, a number of
authors have recognised the occurrence of
enthesitis as part of the RA disease spectrum
[6–8]. It is therefore clear that, by the time the
patient presents, both synovitis and enthesitis
may occur in both conditions, occasionally
making it difficult to distinguish between them
on radiological grounds [9]. However, in estab-
lished disease, differences have been descri-
bed—symmetrical involvement, periarticular
osteopenia and marginal erosions in RA; rela-
tively preserved bone stock, paramarginal ero-
sions, osteolysis, perisostitis and periarticular
new bone in PsA [10].
A clinical enthesis index specific to PsA has
recently been developed [11]. This index
examines tenderness at six sites: lateral epi-
condyles of the humerus, medial condyles of
the femur and the insertion of the Achilles
tendon. The proximity of the lateral epicondyle
of the humerus to the elbow joint (EJ)
exemplifies the difficulties of separating enthe-
seal from articular tenderness, particularly
when both occur together. The aim of the study
reported here was threefold: firstly, to examine
the relationship between enthesitis and syn-
ovitis by comparing data from clinical and
imaging examinations of this anatomical area
in PsA and RA; secondly, to examine the rela-
tionship between clinical enthesitis and enthe-
sitis found on imaging; thirdly, to compare
ultrasound (US) and magnetic resonance imag-
ing (MRI) in terms of identifying features of
enthesitis. We hypothesised (1) that synovitis
would be more prominent in RA, and enthesitis
in PsA; (2) that there would be a poor relation-
ship between clinical enthesitis and enthesitis
identified by US and MRI; (3) that US would
provide more information than MRI on enthe-
sitis at the elbow.
METHODS
Full ethical committee approval was given for
this study, and all patients provided their
signed, informed consent to participate (Brad-
ford REC approval 09/H1302/113). Subjects
were seen in rheumatology out-patient clinics
and, after consent procedures had been com-
pleted, examined using a standard clinical pro-
tocol. Patients with a physician diagnosis of PsA
and RA were eligible if they complained of pain
in the elbow region. The protocol consisted of
gathering sufficient clinical information to
assess the Classification of Psoriatic Arthritis
(CASPAR) criteria [12], an acute phase marker
and a swollen joint count. It included an
assessment of the entheses at the elbow,
namely, the common extensor origin (CEO) at
the lateral epicondyle, the common flexor ori-
gin (CFO) at the medial epicondyle and the
triceps insertion. Pressure was exerted at the
enthesis sufficient to blanch the thumb nail of
the examiner (approximately 4 kg). In addition,
the examiner assessed the presence of soft-tissue
swelling at the enthesis and performed ‘stress’
testing at each site (for medial and lateral epi-
condyles, resisted extension and flexion of the
wrist with the arm fully extended; for triceps,
resisted extension of the elbow).
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Active inflammatory arthritis in the EJ was
assessed by palpation. For the radio-humeral
component (RHJ) the examiner faced the
patient and grasped the hand of the patient in a
gentle handshake (with the right hand for the
right RHJ and the left hand for the left RHJ).
With the thumb of the other hand the examiner
then palpated over the RHJ while supinating/
pronating the forearm. Tenderness and pain on
movement indicated a positive test. Swelling at
this location could not reliably be identified.
For the EJ the examiner palpated the joint line
anteriorly and the groove between the lateral
epicondyle and the olecranon process, noting
soft-tissue swelling and tenderness at this point.
Articular damage was scored if the patient had
more than 50% loss of movement and/or had
bony swelling of the joint margins.
The US and MRI examinations were carried
out on the same day as the clinical evaluation,
with the US images assessed by one radiologist
and the MRI images assessed by a second radi-
ologist; each radiologist was ‘blinded’ to the
diagnosis and to the findings of the ‘other’
imaging modality. After each radiological
examination, the radiologists made a decision
on the diagnosis based on their respective
interpretation of the imaging data. Each radi-
ologist had over 15 years of experience in mus-
culoskeletal radiology. A third radiologist
performed a second reading of both the MRI
and (static) US scans; this radiologist was also
blinded to the diagnosis and to the findings in
each imaging modality.
Ultrasound Protocol
The scans were performed on a Siemens S2000
machine using a 10-15 MHz linear probe (Sie-
mens AG, Munich, Germany). The sono-
graphic assessments were made at the CEO, the
CFO and the attachment of the triceps tendon
at the olecranon. The CEO (anatomically at the
lateral epicondyle of the elbow) was examined
with the patient seated and the hand resting
on the knee with the elbow slightly flexed and
the wrist in gentle internal rotation. The CFO
(anatomically at the medial epicondyle of the
elbow) was examined with the arm fully
extended and the arm resting on the knee with
the palm facing anteriorly. Grey scale imaging
in the longitudinal and transverse planes was
used to assess the enthesis for the presence of
erosions, enthesophytes, entheseal thickening
and perientheseal soft-tissue oedema. Lesions
were scored as present (score 1) or absent (score
0). An erosion was defined as a step-down
cortical contour defect seen in two planes and
measuring C2 mm in depth. An enthesophyte
was defined as a step-up bony prominence at
the end of a normal bone contour and forming
a bony spur seen within the tendinous portion
of the enthesis. Entheseal thickening was
scored as present if there was a discrepancy
between the thickness at the contralateral
enthesis or if the normally smooth entheseal
contours appeared to be bulky. Peri-entheseal
soft-tissue oedema was scored as present if
there was compressible fluid within the soft
tissues on the outer margin of the enthesis.
Assessment of entheseal vascularisation was
performed using Power Doppler mode, with
the pulse repetition frequency set at 600.
Entheseal vascularity was scored as present
(score 1) or absent (score 0).
The following scores were calculated as an
approximation of ‘inflammation’ and ‘damage’
at the enthesis:
(1) Inflammation: vascularisation, fluid in
paratenon, perientheseal soft-tissue
oedema, altered echogenicity and thicken-
ing of tendon (score range 0–5).
(2) Damage: erosion, cortical roughening and
enthesophyte (score range 0–3).
For the joint, both grey scale of effusion/syn-
ovitis and Power Doppler mode were used in
assessment (articular score, range 0–2).
This protocol is in keeping with the recom-
mendations of the OMERACT US in Spondy-
loarthropathy Study Group [13].
MRI Protocol
Scans were performed on a Siemens Avanto 1.5T
scanner (Siemens AG). Patients were imaged
prone in the ‘superman position’ with the arm
extended into the centre of the bore using a
wrap-around coil.
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For the purposes of this study, the following
sequences were performed:
(1) Axial T1-weighted. Repetition time(TR)/
echo time (TE), 300/24 ms; echo-train
length (ETL), 1; matrix, 144 9 192; field
of view (FOV), 11 cm; number of excita-
tions, 1; slice thickness 3 mm with 0.3-mm
interslice gap.
(2) Coronal T1-weighted. TR/TE, 333–361/24
ms; ETL, 1; matrix, 218 9 257; FOV, 13 cm;
number of excitations, 1; slice thickness
3 mm with 0.3-mm interslice gap.
(3) Axial T2 fat-saturated. TR/TE, 2290–4800/
80– ms; ETL, 9–16; matrix, 192 9 256; FOV,
12 cm, number of excitations, 1; slice thick-
ness, 3 mm with 0.3-mm interslice gap.
(4) Coronal short-tau T1 inversion recovery
(STIR). TR/TE, 4630–5130/34 ms; ETL, 7;
matrix, 205 9 256; FOV, 13 cm, number of
excitations, 1; slice thickness, 3 mm with
0.3-mm interslice gap.
A standard dose of 0.2 mL/kg body weight of
gadoterate dimeglumine (Dotarem; Guerbet,
Aulney-sous-Bois, France) was administered
intravenously by hand injection, followed by a
flush of 20 mL saline solution (0.9%). T1
fat-saturated sequences in three orthogonal
planes after gadolinium administration (TR/TE,
580–710/24 ms; ETL, 1; matrix, 218 9 256; FOV,
10 cm; number of excitations, 1; slice thickness,
3 mm with 0.3-mm interslice gap) were subse-
quently obtained.
This protocol is in keeping with the recom-
mendations of the OMERACT MRI Study Group
for PsA [14].
Images were scored in a similar fashion to
the US images as described above. Scores were
calculated as an approximation of ‘inflamma-
tion’ and ‘damage’ at the enthesis, as follows:
(1) Inflammation: fluid in paratenon, peri-en-
theseal soft-tissue oedema, entheseal
enhancement with gadolinium, entheseal
oedema, andboneoedema (score range 0–5).
(2) Damage: erosion, cortical roughening and
enthesophyte (score range 0–3).
Further, images were scored for synovitis in the
elbow and radio-humeral joints, as defined by
the presence of a joint effusion and synovial
enhancement following gadolinium adminis-
tration (Articular score, range 0–2).
Statistics
All statistics were carried out using SPSS soft-
ware v 21.0 (IBM Corp., Armonk, NY). Contin-
uous data were compared using non-parametric
statistics, dichotomous data using Chi-squared
tests and where insufficient cell numbers were
found, we performed a Fisher’s exact test.
Agreement between readers was examined with
the kappa (j) statistic. By general consensus,
kappa values of \0 indicate no agreement,
0–0.20 slight agreement, 0.21–0.40 fair agree-
ment, 0.41–0.60 moderate agreement,
0.61–0.80 substantial agreement and 0.81–1
almost perfect agreement. Intra-class correla-
tion was used to compare the scores of the two
observers.
RESULTS
The study included 20 patients. Of these, 11 had
with PsA [5 males, 6 females; mean age
48.9 years; mean duration of disease 6.8 years;
mean C-reactive protein (CRP) 2.3 mg/dL; mean
swollen joint count 3.4], and nine had RA (4
males, 5 females; mean age 61.9 years; mean
duration of disease 12.4 years; mean CRP
10.5 mg/dL; mean swollen joint count 3.5). All
RA patients fulfilled the 1987 criteria for RA [15]
and eight of the 11 patients with PsA fulfilled
the CASPAR criteria.
Clinical Examination
All patients had a painful elbow. Generally
more patients in the PsA group had clinical
enthesitis (PsA: N = 10 and 8 at the CEO and
CFO, respectively; RA: N = 6 and 4 for CEO
and CFO, respectively), and more patients
with RA had articular involvement (PsA: N = 4
and 3 for EJ and RHJ, respectively; RA: N = 8
and 3 for EJ and RHJ, respectively). The only
statistically significant difference between the
diagnostic groups was for EJ tenderness and
swelling (Chi-squared test 5.7; p = 0.28). Very
few cases of clinical articular damage were
found [2 cases of PsA and 3 cases of rheuma-
toid arthritis (RA)].
74 Rheumatol Ther (2017) 4:71–84
T
ab
le
1
Im
ag
in
g
sc
or
es
fr
om
ul
tr
as
ou
nd
an
d
m
ag
ne
ti
c
re
so
na
nc
e
im
ag
in
g
st
ud
ie
s
at
ea
ch
en
th
es
is
an
d
jo
in
t
ac
co
rd
in
g
to
di
se
as
e
Im
ag
in
g
m
od
al
it
y
P
so
ri
at
ic
ar
th
ri
ti
s
R
he
um
at
oi
d
ar
th
ri
ti
s
In
ﬂa
m
m
at
io
n
D
am
ag
e
In
ﬂa
m
m
at
io
n
D
am
ag
e
V
as
c
Fl
ui
d
ST
O
E
ch
o
T
hi
ck
T
ot
al
E
ro
si
on
C
R
E
nt
h
T
ot
al
V
as
c
Fl
ui
d
ST
O
E
ch
o
T
hi
ck
T
ot
al
E
ro
si
on
C
R
E
nt
h
T
ot
al
U
ltr
as
ou
nd
a
T
R
IC
E
PS
0
0
0
0
0
0
0
0
0.
30
0.
30
0
0
0.
22
0
0.
22
0.
44
0.
22
0
0.
11
0.
33
C
E
O
0.
45
0.
27
0.
18
0.
45
0.
45
1.
82
0
0
0.
55
0.
55
0.
38
0.
13
0
0.
56
0.
44
1.
57
0.
33
0.
63
0.
67
1.
50
C
FO
0.
09
0
0
0
0
0.
09
0
0
0
0
0
0
0
0
0
0
0
0
0
0
E
ff
us
io
n
Po
w
er
D
op
pl
er
?
ve
E
ff
us
io
n
Po
w
er
D
op
pl
er
?
ve
A
rt
ic
ul
ar
0.
36
0.
27
0.
64
0.
22
0.
13
0.
38
Im
ag
in
g
m
od
al
it
y
P
so
ri
at
ic
ar
th
ri
ti
s
R
he
um
at
oi
d
ar
th
ri
ti
s
In
ﬂa
m
m
at
io
n
D
am
ag
e
In
ﬂa
m
m
at
io
n
D
am
ag
e
Fl
ui
d
ST
O
E
nh
an
E
nt
hO
B
on
eO
T
ot
al
E
ro
si
on
C
R
E
nt
h
T
ot
al
Fl
ui
d
ST
O
E
nh
an
E
nt
hO
B
on
eO
T
ot
al
E
ro
si
on
R
ou
gh
E
nt
h
T
ot
al
M
R
Ib T
R
IC
E
PS
0.
18
0.
27
0.
18
0.
18
0
0.
82
0
0
0
0
0
0.
25
0.
25
0.
25
0
0.
75
0
0
0
0
C
E
O
0.
36
0.
64
0.
73
0.
64
0.
18
2.
55
0.
18
0.
27
0.
09
0.
55
0.
13
0.
13
0.
75
0.
75
0.
13
1.
88
0.
13
0.
25
0.
13
0.
50
C
FO
0.
18
0.
36
0.
27
0.
27
0
1.
09
0
0.
09
0
0.
09
0
0.
38
0.
38
0.
13
0
0.
88
0
0
0
0
E
ff
us
io
n
E
nh
an
ce
m
en
t
w
it
h
co
nt
ra
st
E
ff
us
io
n
E
nh
an
ce
m
en
t
w
it
h
co
nt
ra
st
A
rt
ic
ul
ar
1.
18
0.
63
2.
00
0.
63
0.
82
1.
25
A
ll
sc
or
es
re
po
rt
ed
in
th
e
ta
bl
e
ar
e
m
ea
ns
.N
on
e
of
th
e
co
m
pa
ri
so
ns
(s
co
re
s)
be
tw
ee
n
Ps
A
an
d
R
A
in
te
rm
s
of
in
ﬂa
m
m
at
io
n,
da
m
ag
e,
an
d
ar
ti
cu
la
r
w
er
e
si
gn
iﬁ
ca
nt
ly
di
ff
er
en
t
T
R
IC
E
PS
T
ri
ce
ps
in
se
rt
io
n,
C
E
O
co
m
m
on
ex
te
ns
or
or
ig
in
,C
FO
co
m
m
on
ﬂe
xo
r
or
ig
in
,A
rt
icu
la
r
jo
in
t
sc
or
es
a
U
ltr
as
ou
nd
ab
br
ev
ia
ti
on
s:
V
as
c
V
as
cu
la
ri
sa
ti
on
at
en
th
es
is
,F
lu
id
ﬂu
id
in
pa
ra
te
no
n,
ST
O
pe
ri
en
th
es
ea
ls
of
t-
ti
ss
ue
oe
de
m
a,
E
ch
o
al
te
re
d
ec
ho
ge
ni
ci
ty
of
te
nd
on
at
en
th
es
it
is
,T
hi
ck
th
ic
ke
ni
ng
of
te
nd
on
at
en
th
es
is
E
ro
sio
n
er
os
io
n
at
en
th
es
is
,C
R
co
rt
ic
al
ro
ug
he
ni
ng
,E
nt
h
en
th
es
op
hy
te
b
M
R
I
(m
ag
ne
ti
c
re
so
na
nc
e
im
ag
in
g)
ab
br
ev
ia
ti
on
s:
Fl
ui
d
Fl
ui
d
in
pa
ra
te
no
n,
ST
O
pe
ri
en
th
es
ea
ls
of
t-
ti
ss
ue
oe
de
m
a,
E
nh
an
en
th
es
ea
le
nh
an
ce
m
en
t
w
it
h
ga
do
lin
iu
m
,E
nt
hO
en
th
es
ea
lo
ed
em
a,
B
on
eO
bo
ne
oe
de
m
a,
E
ro
sio
n
er
os
io
n
at
en
th
es
is
,C
R
co
rt
ic
al
ro
ug
he
ni
ng
,E
nt
h
en
th
es
op
hy
te
Rheumatol Ther (2017) 4:71–84 75
Imaging Scores by Disease Group
Complete imaging data were not available for
all patients due to one patient not tolerating the
MRI procedure; overall, data on 55/60
comparisons at the three entheseal sites were
available. Scores for both enthesitis and articu-
lar involvement by diagnosis are given in
Table 1. For both diseases the highest scores
were found for inflammation and damage at the
Fig. 1 a Coronal magnetic resonance (MR) short-tau T1
inversion recovery (STIR) imaging. Normal common
extensor origin (CEO) with homogenous low signal
throughout (arrowhead). Note the signal at the CEO
cannot be identiﬁed separately from the lateral collateral
ligament (arrow). There is a small effusion in the joint.
b Ultrasound image. Longitudinal section through the
normal CEO. Fibrils are apparent within the ligament
substance. There is a bright, regular, echogenic paratenon
(arrow), and the slice also shows the edge of the radiocarpal
joint with normal fat pad (star)
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CEO by both imaging modalities (US: PsA mean
inflammation and damage scores of 1.82 and
0.55, respectively; RA mean inflammation and
damage scores of 1.57 and 1.50, respectively;
MRI: PsA mean inflammation and damage
scores of 2.55 and 0.55, respectively; RA mean
Fig. 2 Ultrasound image. Longitudinal section through the CEO. Enthesopathy is present with swollen, hypoechoic CEO,
marked neovascularity in the tendon substance (arrows) and an enthesophyte (arrowhead) close to the tendon insertion
Fig. 3 Coronal MR T1 fat-saturated sequence plus con-
trast. Severe lateral epicondylitis with enhancing, inﬂam-
matory tissue between the oedematous ﬁbres of the
common extensor origin (arrowheads) and multiple small
erosions in the lateral epicondyle (arrow) are visualized. The
lateral collateral ligament is shown separately from the
CEO and is oedematous with a small erosion at the origin
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inflammation and damage scores of 1.88 and
0.50 respectively). None of the differences were
statistically significant.
Relationship Between US and MRI
findings at the Enthesis
The scores for damage differed from those for
inflammation. For damage scores, complete
agreement between US and MRI data was found
in 43/55 (78%) comparisons; in 10/55 (18%)
cases the US data were abnormal but the MRI
data were normal; in 2/55 (4%) cases the MRI
data were abnormal and the US data were
normal.
For inflammation scores complete agree-
ment between US and MRI data was found in
33/55 (60%) comparisons; in 3/55 (5%) cases
the US data were abnormal but the MRI were
normal; in 19/55 (35%) cases the MRI data were
abnormal and US data were normal. Thus, US
appeared to be the more sensitive imaging
modality for evaluating damage and MRI the
more sensitive imaging modality for evaluating
inflammation. Overall unadjusted kappa scores
between US and MRI data were 0.34 for damage
scores and 0.23 for inflammation scores.
Examples of US and MR images at the elbow
are shown in Figs. 1–6.
Relationship Between the Results
of Clinical Examinations and Imaging
Findings
Overall there was a poor agreement between
the clinical findings and the imaging results.
Further, no significant relationship was found
between clinical enthesitis and the presence of
inflammation in the components of the EJ
(data not shown). Kappa scores for agreement
between the clinical and imaging results were
calculated, aggregated for all sites. For the US
inflammation score (any positive) and clinical
tests, the kappa scores for agreement were 0.1,
0.16 and 0.12 for stressing, swelling and ten-
derness, respectively. For the MRI inflamma-
tion scores and clinical tests, the kappa scores
for agreement were 0.28, 0.04 and 0.11 for
stressing, swelling and tenderness, respec-
tively. Levels of agreement at individual loca-
tions were also generally poor, except for the
CEO (stress) and MR inflammation (j = 0.41),
and for CEO tenderness and MR inflammation
(j = 0.28).
Fig. 4 Coronal and axial MR T1 fat-saturated sequence plus contrast. These images show severe ‘osteitis’ with bone oedema
at the origin of the common extensor origin (arrowheads). The CEO is swollen and enhancing (arrows)
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Agreement Between Observers on the Imaging
Agreement between observers was slight to
moderate when aggregated across all entheseal
sites, and for each modality (see Table 2). Kappa
scores were highest for vascularisation (Power
Doppler signal) detected by US (j = 0.51) and
entheseal enhancement detected by MRI (j =
0.32). Interclass correlation (ICC) scores were
also modest for enthesitis, with the largest
scores found for the inflammation scores in the
MRI studies (Triceps 0.59; CEO 0.42; CFO 0.39).
However, ICC scores were good for agreement
on MR inflammation in the EJ (j = 0.86) and US
inflammation in the EJ (j = 0.52).
Observers’ Diagnosis Based on Imaging
There was a poor relationship between the
diagnosis of the primary radiologist, based on
imaging findings, and the clinical diagnosis.
The radiologists were unable to distinguish
between RA and PsA on the basis of imaging
findings. The radiologist interpreting the US
scans ‘misclassified’ 10/17 cases, and the radi-
ologist interpreting the MRI scans ‘misclassified’
7/16 cases. The kappa scores were 0.29 and 0.08
for the level of agreement between US and
clinical diagnoses and between MRI and clinical
diagnoses, respectively.
Fig. 5 a Ultrasound. Longitudinal section through the
common extensor origin. Normal cortical margins and the
ﬁbrils of the CEO are well shown, but there is a partial
thickness tear of the ligament with intra-substance exten-
sion (arrowheads). b Coronal MR T1 fat-saturated
sequence plus contrast. There is a partial thickness tear of
the common extensor origin with distal retraction of the
torn ﬁbres (arrowheads) and normal lateral collateral
ligament (arrows)
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DISCUSSION
The aim of this study was to focus on the
entheses around the EJ in terms of clinical and
imaging findings. US and MR imaging, while
giving contrasting information on inflamma-
tion and damage, remain complementary
modalities. The relationship between clinical
and imaging enthesitis and synovitis was poor.
Further, it was impossible to accurately identify
a disease group from the imaging results alone,
either with US or MRI.
To place some of these findings in context it
is worth noting that abnormalities at the
entheses around the elbow have been demon-
strated in asymptomatic individuals [16] and in
patients with RA in whom clinical inflamma-
tion has subsided [7]. Both these factors are
likely to confound studies looking at the rela-
tionship between clinical and imaging findings
at the enthesis, and in comparing imaging and
clinical findings between diseases. Eshed et al.
recognised that while MRI is sensitive for
enthesopathy, the findings lack specificity and
differentiating between the different aetiologies
of enthesitis on the basis of their MRI charac-
teristics is not always possible [17]. Our study
would appear to confirm this conclusion and
may suggest that the process of entheseal
inflammation is similar in both RA and PsA. US
appeared to be more sensitive for detecting
damage and MRI more sensitive for detecting
inflammation, although a ‘gold standard’, such
as histology, was not available. Nevertheless,
this result is to be expected as the resolution of
MRI is much lower than that of US and, con-
sequently, the former is relatively insensitive to
areas of bony abnormality, such as entheso-
phytes or small erosions.
The discrepancy between clinical and imag-
ing enthesitis in spondyloarthropathy is not a
novel finding [18–20]. This may in part be due
to the fact that clinical examination and imag-
ing studies are measuring different things. For
example, US cannot visualise osteitis, yet ostei-
tis may cause tenderness at the enthesis. Ostei-
tis, or bone oedema, can be visualised at the
enthesis in spondyloarthropathy using MRI,
and this has been interpreted as indicating
enthesitis [21]. However, it was clear that the
relationship between the MRI and clinical
findings in the current study were poor. In a
similar study by Aydin and colleagues in the
knee found an equally poor relationship
Fig. 6 Axial MR STIR sequence. Oedema is evident in the paratenon of the common extensor origin (arrows)
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between imaging and clinical scores [20]. In the
current study one reason for the poor associa-
tion could have been the low prevalence of
abnormality, particularly in the triceps inser-
tion and CFO, and this may disadvantage the
kappa statistic. That a ‘good’ relationship
between MR inflammation and CEO stressing
was found reflects the value of this test and its
relationship to osteitis at the entheseal
insertion.
It had been thought that this study would
show a clear difference between the clinical and
imaging findings of RA and PsA. However, it
must be noted that all the patients included in
this study had established disease, which may
have ‘blurred’ the differences between them.
Further, the mean age of the patients meant
that degenerative enthesopathy could be a
confounding factor. It is possible that the
greater age of the RA patients enrolled in our
study could have influenced the frequency of
degenerative changes at the enthesis but, nota-
bly, inflammatory changes were also found
equally in these diseases. The commonest
abnormalities at each of the three entheseal
sites were found at the CEO, and ‘lateral epi-
condylalgia’ is a common clinical presentation
in primary care in the UK [22].
How do these results inform the use of the
Leeds Enthesitis Index, where the lateral epi-
condyle of the elbow is one of the three sites
examined? The poor relationship between
clinical examination and imaging findings has
been confirmed but, on the positive side, there
was no relationship between inflammation in
the joint and inflammation in the adjacent
enthesis on imaging, and no relationship
between pain at the enthesis and underlying
articular inflammation. The anatomical rela-
tionship of the radio-humeral joint, its capsu-
lar insertion and the CEO suggest that
inflammation in the EJ cannot extend to the
CEO without disruption of the articular cap-
sule at this point, and which in itself may
represent a process of entheseal inflammation
at the capsular insertion. Discriminating
between synovitis and enthesitis at the elbow,
and at other joints, may therefore, and partic-
ularly in established disease, be a futile exercise
because of the inter-relationship between the
two processes.
CONCLUSIONS
In summary, a poor relationship was found
between clinical and imaging assessments, and
between imaging modalities. US seemed the
better modality for assessing damage at the
enthesis, and MRI the better modality for
assessing inflammation. However, MRI is gen-
erally the more sensitive of these two modalities
and should be considered as the next line of
investigation following a normal US result. No
differences were found between PsA and RA in
terms of enthesitis.
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